Ironwood Pharmaceuticals, Inc.
NASDAQ:IRWD
Overview | Financials
 | Company Name | Ironwood Pharmaceuticals, Inc. | 
| Symbol | IRWD | 
| Currency | USD | 
| Price | 1.13 | 
| Market Cap    |  183,550,420 | 
| Dividend Yield    |  0% | 
| 52-week-range | 0.53 - 5.13 | 
| Industry | Drug Manufacturers—Specialty & Generic | 
| Sector | Healthcare | 
| CEO | Mr. Thomas A. McCourt | 
| Website | https://www.ironwoodpharma.com | 
An error occurred while fetching data.
About Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States 
 Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD






